SpeeDx Expand COVID-19 Diagnostics to Include Self-Collected Samples

SpeeDx have added saliva to the list of validated samples for their PlexPCR^® SARS-CoV-2 qPCR diagnostic for COVID-19 sales across Europe^#. A preferred sample type for self-collection and compliance testing programs, the saliva claim will expand the utility of the SpeeDx COVID-19 workflow, and in partnership with the Molgen range of automation, will further support ultra-high throughput testing markets.

“Our automation-compatible workflow is very popular with high-volume laboratories along with the flexibility to pair with a range of extant laboratory equipment to maximise instrument capacity,” said Cassandra Ingles, Director of Clinical and Medical Affairs.

Read the full press release